Aug 5, 2025
Tentative Approval for Generic Lumateperone capsules
Jul 10, 2025
CDP Recognition
Jun 24, 2025
Dr. Reddys API team at CPHI China 2025
Apr 9, 2025
CPHI Japan 2025 - Exhibitor showcase session by Nirav K Shah, Vice President, Head API, North Asia
Apr 9, 2025
Dr. Reddys API team at CPHI Japan 2025
Mar 17, 2025
Dr. Reddys API team at DCAT 2025
Feb 25, 2025
Dr. Reddy’s Wins Big at “Express Pharma Excellence Awards 2025”
Dec 18, 2024
Celebrating Creativity and Festivity: API Calendar Launch 2025!
Nov 29, 2024
Dr. Reddy’s wins CPHI & PMEC India Award for Excellence in Ancillary Pharma Services - Supply Chain & Logistics for enhancing customer experience
Nov 29, 2024
Dr. Reddy’s wins CPHI & PMEC India Award for developing a continuous API manufacturing process.
Nov 29, 2024
Dr. Reddy's API team at CPHI India 2024
Oct 13, 2024
Dr. Reddy's API team at CPHI Milan 2024
Sep 27, 2024
Gunjan Singh at the CPHI Webinar: The Changing Dynamics of Global API Manufacturing
Sep 27, 2024
Karun Gaur at CPHI Milan: Panel Discussion on Pharma Manufacturing in Emerging Markets - Moving Towards Localization in Africa
Jul 8, 2024
Deepak Sapra's Visionary Keynote on Healthcare Innovation at DXEM 2024
May 8, 2024
Dr. Reddy's AI Day: Igniting the Future of Healthcare with Innovation
Apr 25, 2024
USP recognized Dr. Reddy’s with a crystal award for significant contribution towards “New and modernized monograph submissions”
Apr 22, 2024
Dr. Reddy’s API at CPHI Japan 2024
Apr 5, 2024
Dr. Reddys Strategic collaboration with Industrial Promotion Services (IPS) to support the East African Combined Pharmaceutical Center (EACPC) in Kenya
Jan 2, 2024
Dr. Reddy's API Calendar 2024 Unveiling: A Magical Celebration of Creativity, Joy, and Togetherness with Our Global Team's Talented Young Artists
Dec 5, 2023
Dr. Reddy's Pioneers Pharma Advancements Through Strategic Partnerships and Innovation: A Glimpse into Vision 2030: Growth Trajectory and Opportunities for Indian Pharma
Nov 30, 2023
Dr. Reddy’s at CPHI India 2023
Nov 23, 2023
Dr. Reddy’s at 5th CII LIFE SCIENCES SUMMIT 2023 - Making India a Global Pharma and Lifesciences Innovation Hub
Nov 11, 2023
Asia-Pacific Climate Leader Award
Nov 10, 2023
Dr. Reddy’s Achieves AEO-T3 Certification, Elevating Global Trade Facilitation
Oct 28, 2023
Dr. Reddy’s API at CPHI Worldwide 2023
Aug 20, 2023
Dr. Reddys at G20 Summit 2023
Jun 25, 2023
Dr. Reddy’s API at CPHI China 2023
Mar 15, 2023
Being Prepared for What's Next and a Shared Purpose of Serving Patients Whatever it Takes
Feb 15, 2023
Dr. Reddy’s included in Bloomberg Gender-Equality Index for the 6th year in a row and S&P Global’s Sustainability Yearbook for the 3rd year
Jan 5, 2023
Dr. Reddy's API calendar 2023
Nov 6, 2022
Addressing NDMAs in Pharmaceuticals
Nov 5, 2022
Dr.Reddy's at CPHI India 2022 Panel Discussion
Nov 4, 2022
Dr. Reddy’s API received the excellence in API – Technical Documentation award at Aché Laboratórios Parcerias para a Excelência (Partnerships – Excellence) event!
Oct 6, 2022
Dr. Reddy's API participated in the 2022 Pharmaceutical Industry and Regulators Symposium at ANVISA
Sep 27, 2022
Expert statement by Srividya Ramakrishnan, Head, API process engineering, Dr. Reddy’s Laboratories. Published in CHE Manager
Sep 25, 2022
Dr. Reddys attended ACHEMA 2022 Conference
Nov 11, 2021
Dr. Reddy’s API team is a 2021 winner in – API Supplier of the year at Global generics & Biosimilars awards
Nov 11, 2022
COVID-19: Prime Minister of India Meets Pharma leaders
Nov 11, 2021
The winner of the Corporate social responsibility (CSR) Initiative of the year at Global generics & Biosimilars Awards
Oct 7, 2021
2021年美国制造业最佳印度公司的获胜者
Oct 6, 2021
舒更葡糖钠原料药 - 巴西卫生监督局批准的原料药档案适当性函
May 27, 2021
迪帕克•萨普拉谈到了印度国防研究与发展组织的抗新冠病毒药物2DG
May 27, 2021
Dr.Reddy’s gearing up with Covid portfolio: Deepak Sapra, CEO of API & Services, speaks to India Today
Jan 21, 2021
2021年度制药行业最佳供应链团队
Nov 10, 2020
瑞迪博士实验室的阿尼尔•帕特尼 （Anil Patni）在《制造化学家》（Manufacturing Chemist）现场虚拟会上介绍了高效原料药（HPAPIs）
Nov 3, 2020
瑞迪博士实验室在2020年全球仿制药和生物仿制药奖（Global Generics & Biosimilars Awards）上获得“年度原料药供应商”奖
Oct 19, 2020
瑞迪博士在2020年世界医药原料展制药奖（CPhI Pharma Awards 2020）上获得了“卓越制药：可持续发展”类别的荣誉：
Oct 13, 2020
世界医药原料展制药节圆桌会议： 解决亚硝胺污染问题
Oct 5, 2020
瑞迪博士的实验室加入了科学基础目标计划（SBTi），制定了2030年的温室气体排放目标
Oct 5, 2020
世界医药原料展制药节专题讨论：跨境创新： 制药公司和创新者如何抗击新冠病毒病以及前进的道路。
Jul 1, 2020
瑞迪博士与富士胶片和Avigan®（法匹拉韦）全球响应援助机构（Global Response Aid）合作，Avigan®是一种潜在的新冠病毒病治疗药物
Apr 14, 2020
瑞迪博士关于新冠病毒病大流行的报告
Apr 1, 2020
《全球制药视野》上的一篇题为《亚硝胺污染：制药公司对其供应链的重新评估》的文章特别介绍了瑞迪博士。
Apr 1, 2020
左氧氟沙星半水合物（Levofloxacin Hemihydrate）获得欧洲药典适用性认证（CEP）
Mar 1, 2020
阿帕鲁胺的美国药物主文件 - 现已可用
Mar 1, 2020
瑞迪博士2018-19年可持续发展报告
Dec 1, 2019
瑞迪博士的原料药团队搬进其在中国的新办公室
Nov 1, 2019
瑞迪博士的实验室在2019年全球仿制药和生物仿制药奖上获得“年度原料药供应商”奖
免责声明
本網站上的任何信息，包括對任何產品或服務的任何提及，均不構成銷售要約或被解釋為代表銷售要約。受有效專利保護的產品不得提供或供應用於商業用途。但是，在某些情況下，雷迪博士可自行決定並根據當地法律要求，在存在此類監管豁免的任何地方，提供此類產品的研究數量，以根據《印度專利法》第 107A 條（Bolar 豁免）進行監管提交。購買者應對其各自市場的產品或服務（包括專利情況）進行獨立評估，並對所有與專利相關的責任負責。 Dr. Reddy's 不承擔任何明示或暗示的保證，包括但不限於適銷性、適用於特定用途和非侵權的保證。